Athersys (ATHX) Secures New GvHD Patent for MultiStem
BiotechStockTrader.com - 7 hours ago Athersys Inc. (NASDAQ: ATHX), a biopharmaceutical company focused on developing an innovative stem cell platform, similar to companies like Mesoblast (ASX: MSB), Verastem Inc. (NASDAQ: VSTM) and Osiris (NASDAQ: OSIR), recently announced that it was ...



More...